Compare AbCellera Biologics Inc (ABCL) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Williams Companies Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Williams Companies Inc trades at $72.35 (market cap $88.45B). The key difference: Williams Companies Inc is far larger — about 29.6× AbCellera Biologics Inc's market cap, and Williams Companies Inc pays a 2.9% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | WMB | |
|---|---|---|
Market Cap | $2.99B | $88.45B |
Sector | Health | Energy |
52-Week High | $9.76 | $79.40 |
52-Week Low | $2.78 | $56.51 |
Enterprise Value | $2.58B | $119.07B |
Dividend Yield | — | 2.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
